AssetMark Inc’s Evolus EOLS Stock Holding History

AssetMark Inc’s Portfolio EOLS Stock Details EOLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-30	Closed	-$184	–	3407
2025 Q3	$184	Hold	30	–	–	﹤0.01%	3077
2025 Q2	$276	Buy	+30	New	+$307	﹤0.01%	2833

Other funds holding EOLS

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AssetMark Inc's EOLS Position: Q4 2025 in Review

AssetMark Inc sold out of Evolus (EOLS) in Q4 2025, closing a stake of 30 shares — an estimated $184 sold.

AssetMark Inc first reported a position in EOLS in Q2 2025 and held it in 2 quarters. The position peaked at $276 in Q2 2025. 169 funds tracked by Wall St. Rank hold EOLS as of Q4 2025.

AssetMark Inc reported no remaining Evolus position as of Q4 2025 after selling out during the quarter.
AssetMark Inc sold 30 Evolus shares in Q4 2025, an estimated $184.
AssetMark Inc first reported a position in Evolus in Q2 2025 and held it in 2 quarters.
AssetMark Inc's Evolus position peaked at $276 in Q2 2025.
169 funds tracked by Wall St. Rank held Evolus as of Q4 2025.

Based on AssetMark Inc's 13F filing for Q4 2025, filed 23 Jan 2026.